 | • レポートコード：QYR2104Z3736 • 出版社/出版日：QYResearch / 2021年4月15日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、メチシリン感受性黄色ブドウ球菌のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（セファロスポリン、バンコマイシン、リネゾリド、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・メチシリン感受性黄色ブドウ球菌の市場動向 ・企業の競争状況、市場シェア ・メチシリン感受性黄色ブドウ球菌の種類別市場規模（セファロスポリン、バンコマイシン、リネゾリド、その他） ・メチシリン感受性黄色ブドウ球菌の用途別市場規模（病院、クリニック、その他） ・メチシリン感受性黄色ブドウ球菌の北米市場規模2016-2027（アメリカ、カナダ） ・メチシリン感受性黄色ブドウ球菌のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・メチシリン感受性黄色ブドウ球菌のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・メチシリン感受性黄色ブドウ球菌の中南米市場規模2016-2027（メキシコ、ブラジル） ・メチシリン感受性黄色ブドウ球菌の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Dainippon Sumitomo Pharma Co., Ltd、Immtech Pharmaceuticals, Inc.、Lytix Biopharma AS、PharmaIN Corporation、Cubist Pharmaceuticals、Kenta Biotech AG、Arsanis Biosciences GmbH、Volcano Corporation、Abbott Laboratories、AngioScore Inc.） ・結論 |
Methicillin-susceptible staphylococcus aureus infections are caused by gram-positive bacterium, which leads to skin allergies, pneumonia and endocarditis.
Market Analysis and Insights: Global Methicillin-Susceptible Staphylococcus Aureus Market
The global Methicillin-Susceptible Staphylococcus Aureus market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Methicillin-Susceptible Staphylococcus Aureus market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Methicillin-Susceptible Staphylococcus Aureus market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Methicillin-Susceptible Staphylococcus Aureus market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Methicillin-Susceptible Staphylococcus Aureus market.
Global Methicillin-Susceptible Staphylococcus Aureus Scope and Market Size
Methicillin-Susceptible Staphylococcus Aureus market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Methicillin-Susceptible Staphylococcus Aureus market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Treatment and by End Users in terms of revenue and forecast for the period 2016-2027.
Segment by Treatment
Cephalosporins
Vancomycin
Linezolid
Others
Segment by End Users
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Dainippon Sumitomo Pharma Co., Ltd
Immtech Pharmaceuticals, Inc.
Lytix Biopharma AS
PharmaIN Corporation
Cubist Pharmaceuticals
Kenta Biotech AG
Arsanis Biosciences GmbH
Volcano Corporation
Abbott Laboratories
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Treatment: 2016 VS 2021 VS 2027
1.2.2 Cephalosporins
1.2.3 Vancomycin
1.2.4 Linezolid
1.2.5 Others
1.3 Market by Application
1.3.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Share by End Users: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Perspective (2016-2027)
2.2 Methicillin-Susceptible Staphylococcus Aureus Growth Trends by Regions
2.2.1 Methicillin-Susceptible Staphylococcus Aureus Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Methicillin-Susceptible Staphylococcus Aureus Historic Market Share by Regions (2016-2021)
2.2.3 Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Regions (2022-2027)
2.3 Methicillin-Susceptible Staphylococcus Aureus Industry Dynamic
2.3.1 Methicillin-Susceptible Staphylococcus Aureus Market Trends
2.3.2 Methicillin-Susceptible Staphylococcus Aureus Market Drivers
2.3.3 Methicillin-Susceptible Staphylococcus Aureus Market Challenges
2.3.4 Methicillin-Susceptible Staphylococcus Aureus Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Revenue
3.1.1 Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Revenue (2016-2021)
3.1.2 Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Players (2016-2021)
3.2 Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Methicillin-Susceptible Staphylococcus Aureus Revenue
3.4 Global Methicillin-Susceptible Staphylococcus Aureus Market Concentration Ratio
3.4.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Methicillin-Susceptible Staphylococcus Aureus Revenue in 2020
3.5 Methicillin-Susceptible Staphylococcus Aureus Key Players Head office and Area Served
3.6 Key Players Methicillin-Susceptible Staphylococcus Aureus Product Solution and Service
3.7 Date of Enter into Methicillin-Susceptible Staphylococcus Aureus Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Methicillin-Susceptible Staphylococcus Aureus Breakdown Data by Treatment
4.1 Global Methicillin-Susceptible Staphylococcus Aureus Historic Market Size by Treatment (2016-2021)
4.2 Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Treatment (2022-2027)
5 Methicillin-Susceptible Staphylococcus Aureus Breakdown Data by End Users
5.1 Global Methicillin-Susceptible Staphylococcus Aureus Historic Market Size by End Users (2016-2021)
5.2 Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by End Users (2022-2027)
6 North America
6.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
6.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment
6.2.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2021)
6.2.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2022-2027)
6.2.3 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2027)
6.3 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users
6.3.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2021)
6.3.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2022-2027)
6.3.3 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2027)
6.4 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
6.4.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
6.4.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
7.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment
7.2.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2021)
7.2.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2022-2027)
7.2.3 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2027)
7.3 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users
7.3.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2021)
7.3.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2022-2027)
7.3.3 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2027)
7.4 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
7.4.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
7.4.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
8.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment
8.2.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2021)
8.2.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2022-2027)
8.2.3 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2027)
8.3 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users
8.3.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2021)
8.3.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2022-2027)
8.3.3 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2027)
8.4 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region
8.4.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
9.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment
9.2.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2021)
9.2.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2022-2027)
9.2.3 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2027)
9.3 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users
9.3.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2021)
9.3.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2022-2027)
9.3.3 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2027)
9.4 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
9.4.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
9.4.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
10.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment
10.2.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2021)
10.2.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2022-2027)
10.2.3 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2027)
10.3 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users
10.3.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2021)
10.3.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2022-2027)
10.3.3 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2027)
10.4 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
10.4.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Dainippon Sumitomo Pharma Co., Ltd
11.1.1 Dainippon Sumitomo Pharma Co., Ltd Company Details
11.1.2 Dainippon Sumitomo Pharma Co., Ltd Business Overview
11.1.3 Dainippon Sumitomo Pharma Co., Ltd Methicillin-Susceptible Staphylococcus Aureus Introduction
11.1.4 Dainippon Sumitomo Pharma Co., Ltd Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.1.5 Dainippon Sumitomo Pharma Co., Ltd Recent Development
11.2 Immtech Pharmaceuticals, Inc.
11.2.1 Immtech Pharmaceuticals, Inc. Company Details
11.2.2 Immtech Pharmaceuticals, Inc. Business Overview
11.2.3 Immtech Pharmaceuticals, Inc. Methicillin-Susceptible Staphylococcus Aureus Introduction
11.2.4 Immtech Pharmaceuticals, Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.2.5 Immtech Pharmaceuticals, Inc. Recent Development
11.3 Lytix Biopharma AS
11.3.1 Lytix Biopharma AS Company Details
11.3.2 Lytix Biopharma AS Business Overview
11.3.3 Lytix Biopharma AS Methicillin-Susceptible Staphylococcus Aureus Introduction
11.3.4 Lytix Biopharma AS Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.3.5 Lytix Biopharma AS Recent Development
11.4 PharmaIN Corporation
11.4.1 PharmaIN Corporation Company Details
11.4.2 PharmaIN Corporation Business Overview
11.4.3 PharmaIN Corporation Methicillin-Susceptible Staphylococcus Aureus Introduction
11.4.4 PharmaIN Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.4.5 PharmaIN Corporation Recent Development
11.5 Cubist Pharmaceuticals
11.5.1 Cubist Pharmaceuticals Company Details
11.5.2 Cubist Pharmaceuticals Business Overview
11.5.3 Cubist Pharmaceuticals Methicillin-Susceptible Staphylococcus Aureus Introduction
11.5.4 Cubist Pharmaceuticals Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.5.5 Cubist Pharmaceuticals Recent Development
11.6 Kenta Biotech AG
11.6.1 Kenta Biotech AG Company Details
11.6.2 Kenta Biotech AG Business Overview
11.6.3 Kenta Biotech AG Methicillin-Susceptible Staphylococcus Aureus Introduction
11.6.4 Kenta Biotech AG Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.6.5 Kenta Biotech AG Recent Development
11.7 Arsanis Biosciences GmbH
11.7.1 Arsanis Biosciences GmbH Company Details
11.7.2 Arsanis Biosciences GmbH Business Overview
11.7.3 Arsanis Biosciences GmbH Methicillin-Susceptible Staphylococcus Aureus Introduction
11.7.4 Arsanis Biosciences GmbH Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.7.5 Arsanis Biosciences GmbH Recent Development
11.8 Volcano Corporation
11.8.1 Volcano Corporation Company Details
11.8.2 Volcano Corporation Business Overview
11.8.3 Volcano Corporation Methicillin-Susceptible Staphylococcus Aureus Introduction
11.8.4 Volcano Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.8.5 Volcano Corporation Recent Development
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Details
11.9.2 Abbott Laboratories Business Overview
11.9.3 Abbott Laboratories Methicillin-Susceptible Staphylococcus Aureus Introduction
11.9.4 Abbott Laboratories Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.9.5 Abbott Laboratories Recent Development
11.10 AngioScore Inc.
11.10.1 AngioScore Inc. Company Details
11.10.2 AngioScore Inc. Business Overview
11.10.3 AngioScore Inc. Methicillin-Susceptible Staphylococcus Aureus Introduction
11.10.4 AngioScore Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
11.10.5 AngioScore Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Treatment (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cephalosporins
Table 3. Key Players of Vancomycin
Table 4. Key Players of Linezolid
Table 5. Key Players of Others
Table 6. Global Methicillin-Susceptible Staphylococcus Aureus Market Size Growth by End Users (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Methicillin-Susceptible Staphylococcus Aureus Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Methicillin-Susceptible Staphylococcus Aureus Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Regions (2016-2021)
Table 10. Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Regions (2022-2027)
Table 12. Methicillin-Susceptible Staphylococcus Aureus Market Trends
Table 13. Methicillin-Susceptible Staphylococcus Aureus Market Drivers
Table 14. Methicillin-Susceptible Staphylococcus Aureus Market Challenges
Table 15. Methicillin-Susceptible Staphylococcus Aureus Market Restraints
Table 16. Global Methicillin-Susceptible Staphylococcus Aureus Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Players (2016-2021)
Table 18. Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Methicillin-Susceptible Staphylococcus Aureus as of 2020)
Table 19. Ranking of Global Top Methicillin-Susceptible Staphylococcus Aureus Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Methicillin-Susceptible Staphylococcus Aureus Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Methicillin-Susceptible Staphylococcus Aureus Product Solution and Service
Table 23. Date of Enter into Methicillin-Susceptible Staphylococcus Aureus Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2021) (US$ Million)
Table 26. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Treatment (2016-2021)
Table 27. Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Treatment (2022-2027) (US$ Million)
Table 28. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Treatment (2022-2027) & (US$ Million)
Table 29. Global Methicillin-Susceptible Staphylococcus Aureus Market Size Share by End Users (2016-2021) & (US$ Million)
Table 30. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by End Users (2016-2021)
Table 31. Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by End Users (2022-2027) (US$ Million)
Table 32. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by End Users (2022-2027) & (US$ Million)
Table 33. North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2021) (US$ Million)
Table 34. North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2022-2027) & (US$ Million)
Table 35. North America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2021) (US$ Million)
Table 36. North America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2022-2027) & (US$ Million)
Table 37. North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2021) (US$ Million)
Table 40. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2022-2027) & (US$ Million)
Table 41. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2021) (US$ Million)
Table 42. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2022-2027) & (US$ Million)
Table 43. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2021) (US$ Million)
Table 46. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2021) (US$ Million)
Table 48. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2021) (US$ Million)
Table 52. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2022-2027) & (US$ Million)
Table 53. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2021) (US$ Million)
Table 54. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2022-2027) & (US$ Million)
Table 55. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2016-2021) (US$ Million)
Table 58. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Treatment (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2016-2021) (US$ Million)
Table 60. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by End Users (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027) & (US$ Million)
Table 63. Dainippon Sumitomo Pharma Co., Ltd Company Details
Table 64. Dainippon Sumitomo Pharma Co., Ltd Business Overview
Table 65. Dainippon Sumitomo Pharma Co., Ltd Methicillin-Susceptible Staphylococcus Aureus Product
Table 66. Dainippon Sumitomo Pharma Co., Ltd Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
Table 67. Dainippon Sumitomo Pharma Co., Ltd Recent Development
Table 68. Immtech Pharmaceuticals, Inc. Company Details
Table 69. Immtech Pharmaceuticals, Inc. Business Overview
Table 70. Immtech Pharmaceuticals, Inc. Methicillin-Susceptible Staphylococcus Aureus Product
Table 71. Immtech Pharmaceuticals, Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
Table 72. Immtech Pharmaceuticals, Inc. Recent Development
Table 73. Lytix Biopharma AS Company Details
Table 74. Lytix Biopharma AS Business Overview
Table 75. Lytix Biopharma AS Methicillin-Susceptible Staphylococcus Aureus Product
Table 76. Lytix Biopharma AS Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
Table 77. Lytix Biopharma AS Recent Development
Table 78. PharmaIN Corporation Company Details
Table 79. PharmaIN Corporation Business Overview
Table 80. PharmaIN Corporation Methicillin-Susceptible Staphylococcus Aureus Product
Table 81. PharmaIN Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
Table 82. PharmaIN Corporation Recent Development
Table 83. Cubist Pharmaceuticals Company Details
Table 84. Cubist Pharmaceuticals Business Overview
Table 85. Cubist Pharmaceuticals Methicillin-Susceptible Staphylococcus Aureus Product
Table 86. Cubist Pharmaceuticals Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
Table 87. Cubist Pharmaceuticals Recent Development
Table 88. Kenta Biotech AG Company Details
Table 89. Kenta Biotech AG Business Overview
Table 90. Kenta Biotech AG Methicillin-Susceptible Staphylococcus Aureus Product
Table 91. Kenta Biotech AG Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
Table 92. Kenta Biotech AG Recent Development
Table 93. Arsanis Biosciences GmbH Company Details
Table 94. Arsanis Biosciences GmbH Business Overview
Table 95. Arsanis Biosciences GmbH Methicillin-Susceptible Staphylococcus Aureus Product
Table 96. Arsanis Biosciences GmbH Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
Table 97. Arsanis Biosciences GmbH Recent Development
Table 98. Volcano Corporation Company Details
Table 99. Volcano Corporation Business Overview
Table 100. Volcano Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
Table 101. Volcano Corporation Recent Development
Table 102. Abbott Laboratories Company Details
Table 103. Abbott Laboratories Business Overview
Table 104. Abbott Laboratories Methicillin-Susceptible Staphylococcus Aureus Product
Table 105. Abbott Laboratories Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
Table 106. Abbott Laboratories Recent Development
Table 107. AngioScore Inc. Company Details
Table 108. AngioScore Inc. Business Overview
Table 109. AngioScore Inc. Methicillin-Susceptible Staphylococcus Aureus Product
Table 110. AngioScore Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
Table 111. AngioScore Inc. Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Treatment: 2020 VS 2027
Figure 2. Cephalosporins Features
Figure 3. Vancomycin Features
Figure 4. Linezolid Features
Figure 5. Others Features
Figure 6. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by End Users: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Methicillin-Susceptible Staphylococcus Aureus Report Years Considered
Figure 11. Global Methicillin-Susceptible Staphylococcus Aureus Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Methicillin-Susceptible Staphylococcus Aureus Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Regions: 2020 VS 2027
Figure 14. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Regions (2022-2027)
Figure 15. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Players in 2020
Figure 16. Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Methicillin-Susceptible Staphylococcus Aureus as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Methicillin-Susceptible Staphylococcus Aureus Revenue in 2020
Figure 18. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Treatment (2016-2021)
Figure 19. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Treatment (2022-2027)
Figure 20. North America Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Methicillin-Susceptible Staphylococcus Aureus Market Share by Treatment (2016-2027)
Figure 22. North America Methicillin-Susceptible Staphylococcus Aureus Market Share by End Users (2016-2027)
Figure 23. North America Methicillin-Susceptible Staphylococcus Aureus Market Share by Country (2016-2027)
Figure 24. United States Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Methicillin-Susceptible Staphylococcus Aureus Market Share by Treatment (2016-2027)
Figure 28. Europe Methicillin-Susceptible Staphylococcus Aureus Market Share by End Users (2016-2027)
Figure 29. Europe Methicillin-Susceptible Staphylococcus Aureus Market Share by Country (2016-2027)
Figure 30. Germany Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Share by Treatment (2016-2027)
Figure 38. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Share by End Users (2016-2027)
Figure 39. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Share by Region (2016-2027)
Figure 40. China Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Share by Treatment (2016-2027)
Figure 48. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Share by End Users (2016-2027)
Figure 49. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Share by Country (2016-2027)
Figure 50. Mexico Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Share by Treatment (2016-2027)
Figure 54. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Share by End Users (2016-2027)
Figure 55. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Share by Country (2016-2027)
Figure 56. Turkey Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Dainippon Sumitomo Pharma Co., Ltd Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
Figure 60. Immtech Pharmaceuticals, Inc. Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
Figure 61. Lytix Biopharma AS Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
Figure 62. PharmaIN Corporation Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
Figure 63. Cubist Pharmaceuticals Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
Figure 64. Kenta Biotech AG Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
Figure 65. Arsanis Biosciences GmbH Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
Figure 66. Volcano Corporation Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
Figure 67. Abbott Laboratories Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
Figure 68. AngioScore Inc. Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed